• 1.

    Zhao YJ, Ju Q, Li GC. Tumor markers for hepatocellular carcinoma. Mol Clin Oncol. 2013;1:593–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 2.

    Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–55.

    PubMed  Article  Google Scholar 

  • 3.

    Walsh R, Locarnini S. Hepatitis B precore protein: pathogenic potential and therapeutic promise. Yonsei Med J. 2012;53:875–85.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 4.

    Gao J, Xie L, Yang WS, Zhang W, Gao S, Wang J, et al. Risk factors of hepatocellular carcinoma-current status and perspectives. Asian Pac J Cancer Prev. 2012;13:743–52.

    PubMed  Article  Google Scholar 

  • 5.

    Sadamori H, Yagi T, Shinoura S, Umeda Y, Yoshida R, Satoh D, et al. Risk factors for major morbidity after liver resection for hepatocellular carcinoma. Br J Surg. 2013;100:122–9.

    CAS  PubMed  Article  Google Scholar 

  • 6.

    Rasool M, Rashid S, Arooj M, Ansari SA, Khan KM, Malik A, et al. New possibilities in hepatocellular carcinoma treatment. Anticancer Res. 2014;34:1563–71.

    CAS  PubMed  Google Scholar 

  • 7.

    Marquardt JU, Galle PR, Teufel A. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. J Hepatol. 2012;56:267–75.

    PubMed  Article  Google Scholar 

  • 8.

    Zhao X, Huang H, Chen Y, Liu Y, Zhang Z, Ma Q, et al. Dynamic expression of secreted Frizzled-related protein 3 (sFRP3) in the developing mouse spinal cord and dorsal root ganglia. Neuroscience. 2013;248:594–601.

    CAS  PubMed  Article  Google Scholar 

  • 9.

    Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe RF, et al. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res. 2005;65:9762–70.

    CAS  PubMed  Article  Google Scholar 

  • 10.

    Qu Y, Li JF, Cai Q, Wang YW, Gu QL, Zhu ZG, et al. Over-expression of FRZB in gastric cancer cell suppresses proliferation and induces differentiation. J Cancer Res Clin Oncol. 2008;134:353–64.

    CAS  PubMed  Article  Google Scholar 

  • 11.

    Lin YW, Shih YL, Lien GS, Suk FM, Hsieh CB, Yan MD. Promoter methylation of SFRP3 is frequent in hepatocellular carcinoma. Dis Markers. 2014;2014:351863.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  • 12.

    Schlensog M, Magnus L, Heide T, Eschenbruch J, Steib F, Tator M, et al. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients. Epigenetics. 2018;13:214–27.

    PubMed  PubMed Central  Article  Google Scholar 

  • 13.

    Shyam R, Shen X, Yue BY, Wentz-Hunter KK. Wnt gene expression in human trabecular meshwork cells. Mol Vis. 2010;16:122–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  • 14.

    Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep. 2005;14:1583–8.

    CAS  PubMed  Google Scholar 

  • 15.

    Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell. 2003;5:367–77.

    CAS  PubMed  Article  Google Scholar 

  • 16.

    White BD, Chien AJ, Dawson DW. Dysregulation of Wnt/beta-catenin signaling in gastrointestinal cancers. Gastroenterology. 2012;142:219–32.

    CAS  PubMed  Article  Google Scholar 

  • 17.

    Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology. 2007;45:1298–305.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  • 18.

    Lo RC, Leung CO, Chan KK, Ho DW, Wong CM, Lee TK, et al. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/beta-catenin pathway. Cell Death Differ. 2018;25:1426–41.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 19.

    Ueland T, Rollag H, Hartmann A, Jardine AG, Humar A, Michelsen AE, et al. Secreted Wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients. Am J Transpl. 2014;14:210–5.

    CAS  Article  Google Scholar 

  • 20.

    Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG, Qu Q. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio. Pathol Res Pr. 2017;213:824–30.

    Article  Google Scholar 

  • 21.

    Liu YB, Gao SL, Chen XP, Peng SY, Fang HQ, Wu YL, et al. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma. World J Gastroenterol. 2005;11:1378–81.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 22.

    May M, Surcel C, Capitanio U, Dell’Oglio P, Klatte T, Shariat S, et al. Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project). Scand J Urol. 2017;51:269–76.

    CAS  PubMed  Article  Google Scholar 

  • 23.

    Lee J, Park KS, Kang MH, Kim Y, Son SM, Choi H, et al. Primary hepatic peripheral T-cell lymphoma mimicking hepatocellular carcinoma: a case report. Ann Surg Treat Res. 2017;93:110–4.

    PubMed  PubMed Central  Article  Google Scholar 

  • 24.

    Montasser MF, Abdelkader NA, Abdelhakam SM, Dabbous H, Montasser IF, Massoud YM, et al. Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study. World J Hepatol. 2017;9:896–904.

    PubMed  PubMed Central  Article  Google Scholar 

  • 25.

    Ding NH, Zhang L, Xiao Z, Rong ZX, Li Z, He J, et al. NEK4 kinase regulates EMT to promote lung cancer metastasis. J Cell Mol Med. 2018;22:5877–87.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 26.

    Ye Y, Long X, Zhang L, Chen J, Liu P, Li H, et al. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma. Oncotarget. 2016;7:70303–22.

    PubMed  PubMed Central  Article  Google Scholar 

  • 27.

    Momenteau M. The physical chemistry of hemes and hemopeptides. I. Physiochemical properties and reduction of chlorodeuterohemin in organic solvent. Biochim Biophys Acta. 1973;304:814–27.

    CAS  PubMed  Article  Google Scholar 

  • 28.

    Delgado ER, Yang J, So J, Leimgruber S, Kahn M, Ishitani T, et al. Identification and characterization of a novel small-molecule inhibitor of beta-catenin signaling. Am J Pathol. 2014;184:2111–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 29.

    Hagiwara S, Kudo M, Nagai T, Inoue T, Ueshima K, Nishida N, et al. Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma. Br J Cancer. 2012;106:1997–2003.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 30.

    Abitbol S, Dahmani R, Coulouarn C, Ragazzon B, Mlecnik B, Senni N, et al. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of beta-catenin activation. J Hepatol. 2018;68:1203–13.

    CAS  PubMed  Article  Google Scholar 

  • 31.

    Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology. 2015;149:1226–39 e4.

    CAS  PubMed  Article  Google Scholar 

  • 32.

    Satoh W, Matsuyama M, Takemura H, Aizawa S, Shimono A. Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse. Genesis. 2008;46:92–103.

    PubMed  Article  Google Scholar 

  • 33.

    Mukherjee N, Bhattacharya N, Alam N, Roy A, Roychoudhury S, Panda CK. Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance. Cancer Sci. 2012;103:210–20.

    CAS  PubMed  Article  Google Scholar 

  • 34.

    Bernascone I, Gonzalez T, Barea MD, Carabana C, Hachimi M, Bosch-Fortea M, et al. Sfrp3 modulates stromal-epithelial crosstalk during mammary gland development by regulating Wnt levels. Nat Commun. 2019;10:2481.

    PubMed  PubMed Central  Article  Google Scholar 

  • 35.

    Ekstrom EJ, Sherwood V, Andersson T. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion. PLoS ONE. 2011;6:e18674.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  • 36.

    Hari Babu L, Perumal S, Balasubramanian MP. Myrtenal attenuates diethylnitrosamine-induced hepatocellular carcinoma in rats by stabilizing intrinsic antioxidants and modulating apoptotic and anti-apoptotic cascades. Cell Oncol (Dordr). 2012;35:269–83.

    CAS  Article  Google Scholar 

  • 37.

    Zhang ZL, Liu GC, Peng L, Zhang C, Jia YM, Yang WH, et al. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor. Gene Ther. 2018;25:284–96.

    CAS  PubMed  Article  Google Scholar 

  • 38.

    Kephart JJ, Tiller RG, Crose LE, Slemmons KK, Chen PH, Hinson AR, et al. Secreted Frizzled-related protein 3 (SFRP3) is required for tumorigenesis of PAX3-FOXO1-positive alveolar rhabdomyosarcoma. Clin Cancer Res. 2015;21:4868–80.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  • 39.

    Ahsani Z, Mohammadi-Yeganeh S, Kia V, Karimkhanloo H, Zarghami N, Paryan M. WNT1 Gene from WNT signaling pathway is a direct target of miR-122 in hepatocellular carcinoma. Appl Biochem Biotechnol. 2017;181:884–97.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  • 40.

    Liu J, Wang ZC, Tang J, Tang R, Shan X, Zhang W. Hepatitis C virus core protein activates Wnt/beta-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line. Arch Virol. 2011;156:1013–23.

    CAS  PubMed  Article  Google Scholar 

  • 41.

    Gedaly R, Galuppo R, Daily MF, Shah M, Maynard E, Chen C, et al. Targeting the Wnt/beta-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535. PLoS ONE. 2014;9:e99272.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  • 42.

    Wang BM, Li N. Effect of the Wnt/beta-catenin signaling pathway on apoptosis, migration, and invasion of transplanted hepatocellular carcinoma cells after transcatheter arterial chemoembolization in rats. J Cell Biochem. 2018;119:4050–60.

    CAS  PubMed  Article  Google Scholar 

  • Source